RxDoctor Payments Data

Marthe Dika, MD

Dermatology · Burlington, WINPI 1043604424

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,985 of the $14,126 with a category attached, or 70.7%. It is spread thinly across 34 manufacturers, the largest accounting for just 20.0%. Among dermatology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,126in general payments, 2019–2025

Across 613 payments — averaging $23.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Sanofi$2K
  • Sun Pharmaceutical Industries Inc.$2K
  • Lilly USA, LLC$1K
  • Johnson & Johnson$829
  • Amgen$791
  • plus $4K from 28 others
$38,454in research payments, 2019–2025

Across 12 payments — averaging $3204.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$23K
  • Pfizer$16K

What the payments were for

  • Consulting fees$3,54425%
  • Food & beverage$9,98571%
  • Education$5984%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,126 in reported general payments places this provider in the 90th percentile of 260 dermatology providers in Wisconsin.

See all dermatology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$128,778
Medicare patients
227
Services billed
1,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz SyringeIxekizumab11$306,742
Dupixent PenDupilumab14$54,299
Acitretin16$5,355
Fluorouracil30$1,983
Clobetasol Propionate52$1,721
Ketoconazole69$1,153
Doxycycline Hyclate37$1,133
Triamcinolone Acetonide77$646
Hydrocortisone28$134

Paid to pharmacies, not to this prescriber.

Other dermatology in Burlington

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →